RT Journal Article
SR Electronic
T1 HIV-infected patients on cART had similar level of arterial stiffness to the patients with ST-segment elevation myocardial infarction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.08.21249466
DO 10.1101/2021.01.08.21249466
A1 Tomasz Mikula
A1 Magdalena M. Suchacz
A1 Michal Peller
A1 Pawel Balsam
A1 Lukasz Koltowski
A1 Renata Glowczynska
A1 Alicja Wiercinska-Drapalo
A1 Grzegorz Opolski
A1 Krzysztof J. Filipiak
YR 2021
UL http://medrxiv.org/content/early/2021/01/09/2021.01.08.21249466.abstract
AB Background The cardiovascular disease has become very common among HIV-infected patients.Objective The aim was to compare the arterial stiffness and the endothelial dysfunction in healthy HIV-infected patients to non-HIV-infected patients in week 4 after ST-segment elevation myocardial infarction (STEMI).Methods The arterial stiffness was calculated by Endo-PAT 2000 (ITAMAR®) and the endothelial function by Peripheral Arterial Tonometry (PAT®). The correct endothelial function was defined for natural logarithm of reactive hyperaemia index (lnRHI) > 0.51. Arterial stiffness was assessed as the AI and corrected for heart rate of 75 bpm (AI@75).Results Sixty three patients were recruited to this study, 34 subjects with HIV infection (18 on cART) and 29 HIV-negative subjects after recent STEMI. AI was significantly higher in STEMI group than in HIV group. However, after AI@75 standardisation, no statistically significant difference was found between two studied groups. HIV-positive patients on cART had equally high values of arterial stiffness as persons after STEMI. The observed lnRHI results were significantly lower in STEMI group in comparison to HIV-positive patients, and the biggest significant difference was seen between STEMI group and ARV-treated HIV-infected patients.Conclusions ARV-treated HIV-infected patients may have similarly high values of arterial stiffness as non-HIV-infected persons in week 4 after STEMI. More larger studies are required to assess our observation concerning arterial stiffness and elevated risk of cardiovascular disease development in this group of patients, independently of age, smoking status and concomitant chronic diseases.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is not clinical study.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Bioethics Committee of the Medical University of Warsaw.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe confirm the statement regarding the availability of all data referred to in the manuscript.